{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:30:35Z","timestamp":1771306235809,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the value of preoperative prediction of risk factors for recurrence of operable cervical cancer based on the radiomics features of biparametric magnetic resonance imaging (bp-MRI) combined with clinical features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A retrospective collection of cervical cancer cases undergoing radical hysterectomy + pelvic and\/or para-aortic lymph node dissection at the Affiliated Hospital of North Sichuan Medical College was conducted. Region of interest (ROI) was outlined using the 3D Slicer software, and radiomics after feature extraction and feature screening was performed using the least absolute shrinkage and selection operator (LASSO) algorithm. Logistic regression algorithms were used to construct a fusion clinical-radiomics model to visualize nomograms. Receiver operating characteristic (ROC), DeLong test, calibration curve (CC), and decision curve (DC) were used to evaluate the predictive performance and clinical benefit of the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>A total of 99 patients with cervical cancer were included in this study, with 79 and 20 cases in the training and test groups, respectively. Seventeen key features were selected for radiomics model construction. Three clinical features were screened to construct a clinical model. A fusion model of the radiomics model combined with the clinical model was constructed. The area under the curve (AUC) values in the training group were 0.710 (95% CI 0.602\u20130.819), 0.892 (95% CI 0.826\u20130.958), and 0.906 (95% CI 0.842\u20130.970), for the comparative clinical model, radiomics model, and fusion model, respectively, and the AUC values in the testing group were 0.620 (95% CI 0.366\u20130.874), 0.860 (95% CI 0.677\u20131.000), and 0.880 (95% CI 0.690\u20131.000), respectively. The DeLong test showed a statistically significant difference between the AUC values of the fusion model and the clinical model (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Decision curve analysis (DCA) showed that the fusion model had the greatest net benefit when the threshold probability was approximately 0.5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The fusion model constructed based on bp-MRI radiomics features combined with clinical features provides an important reference for predicting the risk status of recurrence in operable cervical cancer. The findings of this study are preliminary exploratory results, and further large-scale, multicenter studies are needed to validate these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1492494","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:12:35Z","timestamp":1740719555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative prediction of recurrence risk factors in operable cervical cancer based on clinical-radiomics features"],"prefix":"10.3389","volume":"15","author":[{"given":"Xue","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunbao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0027","article-title":"NCCN guidelines insights: cervical cancer, version 1.2020","volume":"18","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.6004\/jnccn.2008.0005","article-title":"Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy","volume":"6","author":"Gray","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2010.04.005","article-title":"The biology underlying molecular imaging in oncology: from genome to anatome and back again","volume":"65","author":"Gillies","year":"2010","journal-title":"Clin Radiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.04.035","article-title":"Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer","volume":"138","author":"Wu","year":"2019","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06655-1","article-title":"Preoperative prediction of parametrial invasion in early-stage cervical cancer with MRI-based radiomics nomogram","volume":"30","author":"Wang","year":"2020","journal-title":"Eur Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637794","article-title":"Preoperative prediction of lymphovascular space invasion in cervical cancer with radiomics -based nomogram","volume":"11","author":"Du","year":"2021","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2267::AID-CNCR10>3.0.CO;2-9","article-title":"Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study","volume":"88","author":"Benedetti-Panici","year":"2000","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2022.03.06","article-title":"National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)","volume":"34","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0166311","DOI":"10.1371\/journal.pone.0166311","article-title":"High-grade tumor budding stratifies early-stage cervical cancer with recurrence risk","volume":"11","author":"Huang","year":"2016","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0258","article-title":"The partial area under the summary ROC curve","volume":"24","author":"Walter","year":"2005","journal-title":"Stat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.6004\/jnccn.2015.0055","article-title":"Cervical cancer, version 2.2015","volume":"13","author":"Koh","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13956","article-title":"Risk stratification of early-stage cervical cancer with intermediate-risk factors: model development and validation based on machine learning algorithm","volume":"26","author":"Chu","year":"2021","journal-title":"Oncologist"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)91043-8","article-title":"Prognostic factors in early invasive carcinoma of the uterine cervix. A clinical, histopathologic, and statistical analysis of 343 cases","volume":"146","author":"Larsson","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/COC.0000000000000011","article-title":"Evaluation of clinical and pathologic risk factors may reduce the rate of multimodality treatment of early cervical cancer","volume":"39","author":"Gemer","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.2018.143.issue-S2","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.2019.145.issue-1","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(89)80024-1","article-title":"Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases","volume":"32","author":"Lee","year":"1989","journal-title":"Gynecol Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215207","article-title":"Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer: retrospective single-center study","volume":"15","author":"Mereu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.2018.14.issue-5","article-title":"Lymph nodes metastasis in cervical cancer: Incidences, risk factors, consequences and imaging evaluations","volume":"14","author":"Du","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3802\/jgo.2017.28.e34","article-title":"Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update","volume":"28","author":"Landoni","year":"2017","journal-title":"J Gynecol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1492494\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:12:37Z","timestamp":1740719557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1492494\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":26,"alternative-id":["10.3389\/fonc.2025.1492494"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1492494","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"1492494"}}